EcoDrugPlus

Coagulation Factor Xi

Ensembl ID : ENSMSIG00000027101
Gene Symbol: F11
1 Cross references
231 Possible Orthologues:

Coagulation Factor Xii (Hageman Factor)

Ensembl ID : ENSMSIG00000017816
Gene Symbol: F12
1 Cross references
200 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSMSIG00000002479
Gene Symbol: CSF1R
1 Cross references
221 Possible Orthologues:

Complement Component 1, S Subcomponent 2

Ensembl ID : ENSMSIG00000012192
Gene Symbol: C1S2
1 Cross references
223 Possible Orthologues:

Complement Factor D (Adipsin)

Ensembl ID : ENSMSIG00000002191
Gene Symbol: CFD
1 Cross references
148 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSMSIG00000027321
Gene Symbol: CRHR1
1 Cross references
255 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSMSIG00000029529
Gene Symbol: CCND1
1 Cross references
292 Possible Orthologues:

Cyclin-Dependent Kinase 2

Ensembl ID : ENSMSIG00000000542
Gene Symbol: CDK2
1 Cross references
217 Possible Orthologues:

Cyclin-Dependent Kinase 4

Ensembl ID : ENSMSIG00000019006
Gene Symbol: CDK4
1 Cross references
228 Possible Orthologues:

Cyclin-Dependent Kinase 5

Ensembl ID : ENSMSIG00000004283
Gene Symbol: CDK5
1 Cross references
184 Possible Orthologues:

Cyclin-Dependent Kinase 7

Ensembl ID : ENSMSIG00000002372
Gene Symbol: CDK7
1 Cross references
227 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSMSIG00000009327
Gene Symbol: CYSLTR1
1 Cross references
192 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).